ESTUDIO DE FASE III, ALEATORIZADO, MULTICÉNTRICO, CON GRUPOS PARALELOS Y DE AUSENCIA DE INFERIORIDAD PARA EVALUAR LA EFICACIA, LA SEGURIDAD Y LA TOLERABILIDAD DEL CAMBIO A DOLUTEGRAVIR MÁS LAMIVUDINA EN ADULTOSINFECTADOS POR EL VIH 1 CON SUPRESIÓN VIROLÓGICA.
Datos básicos
- Código:
- 204862
- Protocolo:
- 204862
- EUDRACT:
- 2015-004401-17
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Dotación:
- Año de incio:
- 2018
- Año de finalización:
- 2020
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence
Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda
Editorial Material. 10.1016/j.farma.2024.08.009. 2024
[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Andrés JLP, Solsona MDE
Article. 10.1016/j.farma.2023.10.004. 2024
[Translated article] New challenges in advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2024.05.001. 2024
[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.
Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.12.007. 2025
[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.
Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.09.006. 2024
2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11611. 2021
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain
Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro
Article. 10.33393/grhta.2022.2333. 2022
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
Zozaya, Neboa; (...); Verde, Luis
Article. 10.1017/S0266462322000459. 2022
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.
de Andrés-Nogales F; (...); Martínez-Olmos J
Article. 10.1007/s41669-020-00201-2. 2020
A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.
Casado, MA; (...); Grp MULTIDEX-EMD
Meeting Abstract. 10.1016/j.jval.2018.09.2545. 2018
A new definition and refocus of pharmaceutical care: the Barbate Document
Morillo-Verdugo R; (...); Poveda-Andrés JL
Article. 10.7399/fh.11389. 2020
A NKp80-Based Identification Strategy Reveals that CD56 neg NK Cells Are Not Completely Dysfunctional in Health and Disease.
Orrantia A; (...); Borrego F
Article. 10.1016/j.isci.2020.101298. 2020
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes.
Santos JR; (...); Paredes R
Article. 10.1093/ofid/ofad542. 2023
A young patient with fever after heart transplantation
Ramos, A; (...); Bouza, E
Editorial Material. 2018
ACUTE PARAPARESIS AS CLINICAL PRESENTATION OF VERTEBRAL OSTEOMYELITIS
Fragio-Gil, JJ; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6662. 2019
Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.
Ballesta-López O; (...); Poveda-Andrés JL
Article. 10.1177/1078155220915953. 2020
Adverse outcomes of first-line integrase inhibitor-based single-tablet antiretroviral regimens in the Spanish VACH cohort
Teira, R; (...); Geijo, P
Meeting Abstract. 2018
An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia
Cardozo, C; (...); Garcia-Vidal, C
Article. 10.1093/jac/dkz491. 2020
An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital
Ruiz-Gaitan, A; (...); Peman, J
Article. 10.1111/myc.12781. 2018
-
-
PlumX Metrics
- Citations
- Citation Indexes: 258
- Patent Family Citations: 1
- Policy Citations: 1
- Captures
- Readers: 223
- Mentions
- Blog Mentions: 3
- News Mentions: 51
Analysing criteria for price and reimbursement of orphan drugs in Spain.
Badia, X; (...); Tort, M
Article. 10.7399/fh.11147. 2019
-
-
PlumX Metrics
- Citations
- Citation Indexes: 11
- Usage
- Full Text Views: 375
- Abstract Views: 42
- Captures
- Readers: 57
Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/10781552211038518. 2021
Antimicrobial stewardship programme implementation in a medical ward
Ruiz, J; (...); Poveda, JL
Article. 2018
Antimicrobial stewardship programme in critical care medicine: A prospective interventional study
Ruiz, J; (...); Catellanos, A
Article. 10.1016/j.medin.2017.07.002. 2018
Anti-neutrophil cytoplasmic antibody-positive vasculitis presenting with periaortitis and muscle vasculitis in a patient with chronic Chagas disease.
Garcia-Bustos V; (...); Moral Moral P
Letter. 10.1080/03009742.2019.1701073. 2020
Anti-neutrophil cytoplasmic antibody-positive vasculitis presenting with periaortitis and muscle vasculitis in a patient with chronic Chagas disease: comment on the letter by Garcia-Bustos et al Reply
Garcia-Bustos V; (...); Moral Moral P
Letter. 10.1080/03009742.2020.1756401. 2020
Antiretroviral therapy without nucleoside reverse transcriptase inhibitors: dual therapy with darunavir/p and rilpivirine. Safety and efficacy in clinical practice. RIDAR 2
Arazo, P; (...); Pasquau, J
Meeting Abstract. 2018
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).
Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ
Letter. 10.1111/jdv.19432. 2023
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
Bayesian pharmacokinetic individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A
Megias-Vericat, JE; (...); Bonanad, S
Meeting Abstract. 2018
Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2018.12.027. 2019
Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial.
Tenorio CH; (...); Vallecillos CG
Article. 10.1016/j.ijantimicag.2024.107164. 2024
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
Fernandez Rivera C; (...); Hernandez D
Article. 10.1111/ctr.14550. 2022
Cellulitis in adult patients: A large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment
Collazos, J; (...); Asensi, V
Article. 10.1371/journal.pone.0204036. 2018
Central nervous system infections in immunocompromised patients
Castro, I; (...); Salavert, M
Article. 2018
Circulating extracellular vesicles in sera of chronic patients as a method for determining active parasitism in Chagas disease
Lozano, Noelia; (...); Osuna, Antonio
Article. 10.1371/journal.pntd.0012356. 2024
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2021.07.009. 2021
Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model
Nogueras, A; (...); Calleja, MA
Letter. 10.1136/ejhpharm-2019-001905. 2019
Clinicoepidemiological characteristics of viral hepatitis in migrants and travellers of the plus Redivi network
Henriquez-Camacho, C; (...); Redivi Study Grp
Article. 10.1016/j.tmaid.2019.02.001. 2019
-
PlumX Metrics
- Citations
- Policy Citations: 4
- Citation Indexes: 7
- Captures
- Readers: 52
- Mentions
- News Mentions: 1
Collaborative model of home delivery program in haemophilia through an association of patients
Megias-Vericat, JE; (...); Bonanad, S
Meeting Abstract. 2018
Comparison of antiretroviral treatment initiation in HIV newly diagnosed adolescents in Spain
Torres-Fernandez, D.; (...); Navarro, M. L.
Meeting Abstract. 2019
Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo
Megias-Vericat, JE; (...); Poveda, JL
Meeting Abstract. 2020
COMPUTER TOMOGRAPHY GUIDED BIOPSY YIELD IN PYOGENIC VERTEBRAL OSTEOMYELITIS. AN EXAMINATION OF INFLUENCING FACTORS
Fragio-Gil, JJ; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6627. 2019
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano JB; (...); Soto-Ortega I
Article. 10.1016/j.farma.2023.01.003. 2023
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada
Article. 10.1016/j.farma.2023.04.002. 2023
COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA
Gironella, M.; (...); Oyaguez, I
Meeting Abstract. 2019
COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN
Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.
Meeting Abstract. 2024
Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.
Poveda JL; (...); Torres C
Article. 10.1080/14737167.2019.1635014. 2020
COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN
Trillo, JL; (...); Torres, C
Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018
COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN
Bonanad, S; (...); Gonzalez-Dominguez, A
Meeting Abstract. 2020
Costs of the management of hemophilia A with inhibitors in Spain
Bonanad, S; (...); Gonzalez-Dominguez, A
Article. 10.33393/grhta.2021.2234. 2021
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis
Megias-Vericat, JE; (...); Poveda, JL
Letter. 10.1111/hae.13733. 2019
Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products
Eduardo Megias, Juan; (...); Iorio, Alfonso
Meeting Abstract. 10.1182/blood-2019-127946. 2019
Current management of CMV infection in cancer patients (solid tumors). Epidemiology and therapeutic strategies.
Garcia-Bustos, Victor; (...); Blanes, Marino
Article. 10.37201/req/s03.16.2022. 2022
Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.
Garrido-Jareño M; (...); Pemán-García J
Article. 10.1186/s13071-020-3901-1. 2020
Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.
Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL
Editorial Material. 10.1016/j.farma.2024.08.001. 2024
Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors
Asensi, V; (...); Pineda, JA
Article. 10.1371/journal.pone.0221598. 2019
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57).
Podzamczer D; (...); Moreno S
Article. 10.1093/ofid/ofab595. 2022
Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review
Megias-Vericat, JE; (...); Montesinos, P
Review. 10.1080/17512433.2019.1573668. 2019
Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project
Blade, J; (...); Lizan, L
Article. 10.1136/bmjopen-2017-018850. 2018
Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.
Salinas P; (...); Escaned J
Article. 10.1016/j.carrev.2021.11.015. 2021
Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients
Ruiz-Gaitan, Alba; (...); Peman, Javier
Article. 10.1080/14787210.2019.1592675. 2019
Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy
Gras, L; (...); Antiretroviral Therapy Cohort
Article. 10.1097/QAI.0000000000001913. 2019
Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis
Alvarez-Roman, MT; (...); Badia, X
Article. 10.1177/2284240319880534. 2019
DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Alvarez, E.; (...); Badia, F. J.
Meeting Abstract. 2019
Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
Abad, Maria Reyes; (...); Gil, Alicia
Article. 10.33393/grhta.2024.3041. 2024
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis
Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther
Article. 10.1002/jvc2.275. 2024
DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN
Poveda, J. L.; (...); Vitoria, I
Meeting Abstract. 2019
Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain
Badia, X; (...); Poved, JL
Article. 10.1080/21678707.2019.1652163. 2019
Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014.
Muñoz Hornero C; (...); Pérez-Elías MJ
Article. 10.1016/j.eimc.2020.05.021. 2021
Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014.
Muñoz Hornero C; (...); Pérez-Elías MJ
Article. 10.1016/j.eimce.2021.07.003. 2021
Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI.
Castro I; (...); Salavert M
Article. 2019
Does Autoimmunity Play a Role in the Immunopathogenesis of Vasculitis Associated With Chronic Chagas Disease?
Garcia-Bustos, V; (...); Munoz, EC
Editorial Material. 10.3389/fcimb.2021.671962. 2021
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks).
Hidalgo-Tenorio, Carmen; (...); Garcia-Vallecillos, Coral
Article. 10.3390/v14030524. 2022
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study.
Troya, Jesus; (...); Buzon, Luis
Article. 10.1097/MD.0000000000029252. 2022
Durability of first-line antiretroviral regimens in the era of integrase inhibitors: a cohort of HIV-positive individuals in Spain, 2014-2015.
Jarrin I; (...); Cohort of the Spanish HIV
Article. 10.3851/IMP3297. 2019
Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.
Perez Elias MJ; (...); Martinez E
Article. 10.1093/jac/dkaa547. 2021
Early Detection of Cancer and Precancerous Lesions in Persons with HIV through a Comprehensive Cancer Screening Protocol.
Gutierrez, Felix; (...); Masia, Mar
Article. 10.1093/cid/ciae359. 2024
Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan
Ribera, E; (...); Hernandez-Novoa, B
Article. 10.1016/j.eimc.2016.11.015. 2018
Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.
Torres Martínez E; (...); Vento M
Article. 10.1016/j.anpedi.2020.03.009. 2020
Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients
Cordero, E; (...); Perez-Romero, P
Article. 10.3389/fimmu.2020.01917. 2020
Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters
Corona, Diana; (...); Rivero, Antonio
Article. 10.1016/j.ijantimicag.2023.107016. 2024
Effectiveness and safety of integrase strand transfer inhibitors in Spain: a prospective real-world study.
Santos JR; (...); Paredes R
Article. 10.3389/fcimb.2023.1187999. 2023
Effectiveness and tolerability of dolutegravir and abacavir/lamivudine administered as two separate pills compared to their equivalent single-tablet regimen in treatment-naive and treatment-experienced patients
Suarez-Garcia, I.; (...); Jarrin, I.
Meeting Abstract. 2021
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment
Palanques-Pastor T; (...); Poveda Andrés JL
Article. 10.1159/000517813. 2021
Effectiveness, safety/tolerability of OBV/PTV/r DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.
Londoño MC; (...); García-Buey L
Article. 10.1371/journal.pone.0221567. 2019
-
-
PlumX Metrics
- Citations
- Citation Indexes: 5
- Policy Citations: 2
- Captures
- Readers: 54
- Mentions
- News Mentions: 1
Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.
Palacios, R.; (...); Santos, J.
Article. 10.1111/hiv.13489. 2023
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort
Teira, R; (...); Espinosa, N
Article. 10.1080/25787489.2021.1955197. 2021
eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice
Bonanad, S; (...); Megias-Vericat, JE
Meeting Abstract. 2018
Enterococcus spp. and Streptococcus spp. bloodstream infections: epidemiology and therapeutic approach.
Blanes Hernández R, Blanes Juliá M
Article. 10.37201/req/s01.01.2023. 2023
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.
Fanciulli C; (...); González Garcia J
Article. 10.1111/hiv.13229. 2022
-
-
PlumX Metrics
- Citations
- Citation Indexes: 11
- Policy Citations: 3
- Captures
- Readers: 23
- Mentions
- News Mentions: 1
Epidemiology and clinical description of Chagas disease in Valencia, Spain, from 2010 to 2020
Lozano, Noelia; (...); Calabuig, Eva
Article. 10.1016/j.actatropica.2024.107458. 2024
Etiology, diagnosis, and management of pneumonia in immunosuppressed patients.
Salavert Lleti, Miguel; (...); Garcia-Bustos, Victor
Article. 10.37201/req/s01.20.2022. 2022
EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN
Badia, F. J.; (...); Shepherd, J.
Meeting Abstract. 2019
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.
Ruiz-Rodriguez P; (...); Coscolla M
Article. 10.1128/mBio.02315-21. 2021
Evolving understanding of cardiovascular, cerebrovascular and peripheral arterial disease in people living with HIV and role of novel biomarkers. A study of the Spanish CoRIS cohort, 2004-2015
Masia, M; (...); Gutierrez, F
Article. 10.1371/journal.pone.0215507. 2019
Executive Summary of the Consensus Statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Tropical Medicine and International Health (SEMTSI), the Spanish Association of Surgeons (AEC), the Spanish Society of Pneumology and Thoracic Surgery (SEPAR), the Spanish Society of Thoracic Surgery (SECT), the Spanish Society of Vascular and Interventional Radiology (SERVEI), and the Spanish Society of Paediatric Infectious Diseases (SEIP), on the Management of Cystic Echinococcosis.
Belhassen-Garcia M; (...); Velasco Pelayo L
Article. 10.1016/j.eimc.2019.10.015. 2020
Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases.
Len O; (...); Domínguez-Gil B
Article. 10.1016/j.eimc.2019.10.016. 2019
Experience of a fungal infection after cardiac surgery
Vicente-Martinez, L; (...); Argente, P
Article. 10.1016/j.redar.2019.01.012. 2019
Exploratory analysis for the implementation of antineoplastic logarithmic dose banding
Albert-Mari, A; (...); Poveda-Andres, JL
Article. 10.1007/s11096-018-0714-9. 2018
EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY
F, de Andres-Nogales; (...); Martinez, M.
Meeting Abstract. 2019
Factors associated with late presentation for HIV care in adolescents in Spain
Epalza, Cristina; (...); Luisa Navarro, Maria
Article. 10.1111/hiv.13407. 2022
Factors associated with sepsis development in 606 Spanish adult patients with cellulitis
Collazos, J; (...); Asensi, V
Article. 10.1186/s12879-020-4915-1. 2020
Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts
Bassetti M; (...); Munoz, P
Article. 10.1186/s13054-020-2793-y. 2020
Factors associated with the number of drugs in darunavir/cobicistat regimens.
Martinez E; (...); Perez-Elias MJ
Article. 10.1093/jac/dkz399. 2020
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease
Beltran, B; (...); Nos, P
Article. 10.1159/000492626. 2019
Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report
Fernandez-Sanchez, M; (...); Poveda-Andres, JL
Article. 10.1002/bdr2.1942. 2021
Frequency and characteristics of HTLV in migrants: Results from the +Redivi collaborative network in Spain.
Norman FF; (...); López-Vélez R
Article. 10.1093/jtm/taac019. 2022
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.
Plaza J; (...); Moret-Tatay I
Article. 10.3390/ijms25073717. 2024
Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis
Editorial Material. 2022
Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report
Company-Albir, MJ; (...); Poveda, JL
Article. 10.1111/jcpt.12568. 2017
Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study
Valero-Garcia, S; (...); Spanish Hosp Pharmacy Units
Article. 10.7399/fh.10935. 2018
-
-
PlumX Metrics
- Citations
- Citation Indexes: 5
- Usage
- Full Text Views: 216
- Abstract Views: 39
- Captures
- Readers: 19
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
Solana-Altabella, Antonio; (...); Martinez-Cuadron, David
Article. 10.3390/cancers14081921. 2022
Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients
Merchante, N; (...); GEHEP-002 Study Grp
Article. 10.1097/QAD.0000000000001809. 2018
Heterogeneity in Cystic Echinococcosis Management Among Spanish Centers: Results from a National Survey
Salvador, F; (...); Belhassen-Garcia, M
Article. 10.4269/ajtmh.19-0960. 2020
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.
El-Qutob D; (...); Carrera-Hueso FJ
Article. 10.1016/j.hrtlng.2022.02.003. 2022
High Plasma Levels of sTNF-R1 and CCL11 Are Related to CD4+T-Cells Fall in Human Immunodeficiency Virus Elite Controllers With a Sustained Virologic Control
Gutierrez-Rivas, M; (...); ECRIS Integrated Spanish AIDS Res
Article. 10.3389/fimmu.2018.01399. 2018
HIV/HBV coinfection in Spain: prevalence and clinical characteristics
Perez Latorre, L.; (...); Gonzalez-Garcia, J.
Meeting Abstract. 2019
HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018
Perez-Latorre, L; (...); Gonzalez-Garcia, J
Article. 10.2807/1560-7917.ES.2021.26.25.2000236. 2021
Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies
Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo
Article. 10.7399/fh.11729. 2022
Hospitalization budget impact during the COVID-19 pandemic in Spain.
Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.
Article. 10.1186/s13561-021-00340-0. 2021
How can artificial intelligence optimize value-based contracting?
Poveda, Jose Luis; (...); Medrano, Ignacio H.
Letter. 10.1186/s40545-022-00475-3. 2022
How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort
Suarez-Garcia, I; (...); Hernando, V
Article. 10.1186/s12905-021-01370-w. 2021
Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant
Berenguer, J; (...); GeSIDA 8514 Study Grp
Article. 10.1093/ofid/ofx258. 2018
-
-
PlumX Metrics
- Citations
- Citation Indexes: 22
- Policy Citations: 2
- Captures
- Readers: 55
- Mentions
- News Mentions: 1
IL7RA rs6897932 Polymorphism is Associated with Better CD4 + T-Cell Recovery in HIV Infected Patients Starting Combination Antiretroviral Therapy.
Resino S; (...); CoRIS and the HIV Biobank integrated in the Spanish AIDS Research Network Projec
Article. 10.3390/biom9060233. 2019
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection.
Masiá M; (...); Martínez E
Article. 10.1186/s13063-021-05777-6. 2021
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection (vol 22, 851, 2021)
Masia, M.; (...); Martinez, E.
Correction. 10.1186/s13063-023-07655-9. 2023
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1080/10428194.2020.1839650. 2020
Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients
Merchante, N; (...); Pineda, JA
Article. 10.1097/QAD.0000000000002578. 2020
Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019
Badia X; (...); Hernández C
Article. 10.1186/s13023-020-01507-4. 2020
Impact of voriconazole plasma concentrations on treatment response in critically ill patients
Ruiz, J; (...); Ramirez, P
Article. 10.1111/jcpt.12817. 2019
Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases
Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL
Article. 10.7399/fh.11262. 2020
Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.1159/000478969. 2018
Imported Arbovirus Infections in Spain, 2009-2018
Norman, FF; (...); Lopez-Velez, R
Article. 10.3201/eid2604.190443. 2020
Imported cysticercosis in Spain: A retrospective case series from the +REDIVI Collaborative Network.
Herrador Z; (...); López-Vélez R
Article. 10.1016/j.tmaid.2020.101683. 2020
Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir+Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study.
Mussini, Cristina; (...); van Wyk, Jean
Article. 10.1007/s10461-024-04490-0. 2024
Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A
Vericat, JEM; (...); Bonanad, S
Meeting Abstract. 2018
INFECTIOUS SPONDYLODISCITIS: 7-YEAR ANALYSIS OF CLINICAL AND PROGNOSTIC VARIABLES IN A TERTIARY HOSPITAL
Fragio, J; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2018-eular.7272. 2018
Infective endocarditis due to Tropheryma whipplei: A current challenge
Dominguez-Massa, C; (...); Hornero-Sosa, F
Article. 10.1016/j.circv.2019.01.076. 2019
Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy
Bastida, G; (...); Nos, P
Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019
Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1080/10428194.2017.1323267. 2017
Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.
Ruiz J; (...); Poveda JL
Article. 10.23736/S0026-4946.18.04978-2. 2018
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1097/FPC.0000000000000431. 2021
Integrase strand-transfer inhibitors for treatment of early HIV infection A case series
Teira, R; (...); Montero, M
Article. 10.1097/MD.0000000000016866. 2019
Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients
Minguez, C; (...); COINFECOVA-2 Study Grp
Article. 10.1097/QAD.0000000000001699. 2018
Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report
Company-Albir, MJ; (...); Poveda, JL
Article. 10.1111/jcpt.12842. 2019
Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma
Blanes, M; (...); de la Rubia, J
Letter. 10.1007/s00277-019-03663-5. 2019
Intravenous Busulfan-Melphalan vs Melphalan as Preparative Regimen for Newly Diagnosed Multiple Myeloma: Long-Term Follow-Up of a Case-Control Study
Blanes, M; (...); de la Rubia, J
Meeting Abstract. 10.1016/j.clml.2019.09.473. 2019
Intravenous busulphan plus melphalan versus melphalan alone as conditioning regimen for newly diagnosed patients with multiple myeloma: Long-term follow-up of a matched case-controlled study
Blanes, M; (...); de la Rubia, J
Meeting Abstract. 2019
Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
Solana-Altabella A; (...); Poveda JL
Article. 10.1177/1078155220904410. 2020
Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19
Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP
Article. 10.1136/ejhpharm-2020-002322. 2020
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.
Álvarez H; (...); Poveda E
Article. 10.3389/fimmu.2023.1257725. 2023
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
Pozo-Rosich P; (...); Irimia P
Article. 10.1186/s10194-024-01747-w. 2024
Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula
Article. 10.3390/antibiotics13080706. 2024
Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain
Serrano-Villar, Sergio; (...); de Isla, Leopoldo Perez
Article. 10.1016/j.eimc.2023.07.005. 2024
Knowledge, attitudes and practices in HIV-related chronic inflammation and cardiovascular risk in Spain.
Serrano-Villar, Sergio; (...); Perez de Isla, Leopoldo
Article. 10.1016/j.eimce.2023.07.009. 2023
Laboral Cranio-Facial Cellulitis with Perichondritis and External Otitis, A Case Report
Moreno, Eloy Sempere, Barcelo, Santos Ibanez, Alonso, Marta Montero
Editorial Material. 10.1016/j.eimc.2024.02.008. 2024
Laboral cranio-facial cellulitis with perichondritis and external otitis, a case report.
Sempere Moreno, Eloy, Ibanez Barcelo, Santos, Montero Alonso, Marta
Case Reports. 10.1016/j.eimce.2024.04.004. 2024
Lack of impact of protease inhibitor resistance-associated mutations on the outcome of HIV-1-infected patients switching to darunavir-based dual therapy
Vizcarra, P; (...); Moral, SD
Article. 10.1080/23744235.2019.1694696. 2020
Long or complicated mpox in patients with uncontrolled HIV infection.
Corma-Gómez A; (...); Macías J
Article. 10.1002/jmv.29511. 2024
Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy
Martinez-Camprecios, J; (...); Buti, M
Meeting Abstract. 2021
Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy.
Tarancon-Diez, Laura; (...); Muñoz-Fernández MÁ
Article. 10.1016/j.biopha.2023.114587. 2023
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Martinez-Camprecios, Joan; (...); Buti, Maria
Article. 10.1016/j.gastrohep.2022.12.004. 2023
-
PlumX Metrics
- Citations
- Policy Citations: 1
- Citation Indexes: 1
- Captures
- Readers: 13
- Mentions
- News Mentions: 1
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV( vol 106, pg 136, 2024)
Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.
Correction. 10.1016/j.kint.2024.10.002. 2024
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.
Pelchen-Matthews, Annegret; (...); Wyatt, Christina M.
Article. 10.1016/j.kint.2024.04.010. 2024
Losses to follow-up of HIV-infected people in the Spanish VACH cohort over the period between 2013 and 2014: The importance of sociodemographic factors
Teira, R; (...); Grp Estudio VACH
Article. 10.1016/j.eimc.2018.09.008. 2019
Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients
Merchante, N; (...); GEHEP-002 Study Grp
Article. 10.1097/QAD.0000000000002065. 2019
Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count
Ruiz-de-Leon, MJ; (...); Sierra, O
Article. 10.1016/j.jmii.2018.07.007. 2019
Maintenance of virologic suppression and improvement in comorbidities after simplification to raltegravir plus boosted darunavir among treatment-experienced HIV-infected patients
Casado, JL; (...); De Santiago, AD
Article. 10.1177/0956462419896478. 2020
Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.
Megías-Vericat JE; (...); Poveda-Andrés JL
Article. 2021
Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.
Vázquez Polo A; (...); Vázquez Costa JF
Article. 10.20960/nh.03946. 2022
Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
Bonanad, S; (...); Santos, S
Article. 10.1007/s12325-021-01853-0. 2021
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Article. 10.3390/cancers14030596. 2022
Metyrapone as treatment in the neonatal McCune-Albright syndrome
de Mingo, Carmen; (...); Garcia-Robles, Ana
Article. 10.1515/jpem-2020-0036. 2020
Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study
Garcia-Broncano, P; (...); GESIDA 3603b Study Grp
Article. 10.1016/j.jinf.2019.09.020. 2020
Mitochondrial haplogroup H is related to CD4+T cell recovery in HIV infected patients starting combination antiretroviral therapy
Medrano, LM; (...); Spanish AIDS Res Network Project
Article. 10.1186/s12967-018-1717-y. 2018
Mitral repair results in endocarditis
Dominguez-Massa, C; (...); Montero-Argudo, JA
Article. 10.1016/j.circv.2020.08.005. 2020
Monitoring coagulation factors during surgery. A systematic review
Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11766. 2021
Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).
Valero-García S; (...); Delgado-Sánchez O
Article. 10.7399/fh.11655. 2021
Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program.
Fernandez-Megia, MJ; (...); Poveda Andrés JL
Article. 10.7399/fh.10793. 2018
-
-
PlumX Metrics
- Citations
- Citation Indexes: 4
- Usage
- Full Text Views: 693
- Abstract Views: 33
- Captures
- Readers: 34
Monocyte Activation and Ageing Biomarkers in the Development of Cardiovascular Ischaemic Events or Diabetes in People with HIV.
Bernardino, Jose I.; (...); Rodes, Berta
Article. 10.3390/microorganisms11071818. 2023
Mortality in Perinatally HIV-infected Adolescents After Transition to Adult Care in Spain.
Berzosa Sánchez A; (...); Ramos Amador JT
Article. 10.1097/INF.0000000000003009. 2021
Multidrug resistant bacterial infections after liver transplantation: prevalence, impact and associated risk factors
Martin-Mateos, Rosa; (...); Albillos, Agustin
Meeting Abstract. 2022
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.
Martin-Mateos R; (...); Albillos A
Article. 10.1016/j.jhep.2024.02.023. 2024
Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation
Lopez-Medrano, F; (...); Swiss Transplant Cohort Study STCS
Article. 10.1016/j.cmi.2017.06.016. 2018
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
Gomez-Cebrian, N; (...); Pineda-Lucena, A
Review. 10.3390/cancers13184544. 2021
National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)
Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel
Correction. 10.7399/fh.11740. 2021
National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies
Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis
Meeting Abstract. 10.1182/blood-2022-169938. 2022
New challenges of advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2023.11.008. 2024
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.
Poveda JL; (...); Badia X
Article. 10.1186/s13023-022-02610-4. 2023
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Review. 10.3390/biology12091159. 2023
Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice
Bonanad, S; (...); Poveda, JL
Meeting Abstract. 2018
OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT
Flores-Moreno, S.; (...); Gil, A.
Meeting Abstract. 2024
Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316)
Perez Elias, MJ; (...); CODAR Study Grp
Article. 10.1093/jac/dkz254. 2019
-
PlumX Metrics
- Citations
- Policy Citations: 3
- Citation Indexes: 2
- Captures
- Readers: 15
- Mentions
- News Mentions: 1
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
Garcia-Robles, Ana; (...); Carrascosa, MA
Article. 10.3389/fped.2020.00372. 2020
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Correction. 10.3389/fped.2021.834454. 2022
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project
Morillo-Verdugo, R; (...); Diaz-Olmo, J
Article. 10.7399/fh.11719. 2021
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.
Morillo-Verdugo R; (...); Díaz-Olmo J
Article. 2021
Peritransplant Antiviral Treatment of Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients
Vinaixa, C; (...); Prieto, M
Letter. 10.1002/lt.25297. 2018
Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy
Margusino-Framiñán L; (...); Morillo-Verdugo R
Article. 10.7399/fh.11498. 2020
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis
Article. 10.3390/ijms26041760. 2025
Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia
Megias-Vericat, JE; (...); Montesinos, P
Review. 10.2174/1389200218666171101124931. 2018
Pharmacometabolomics by NMR in Oncology: A Systematic Review.
Gómez-Cebrián N; (...); Pineda-Lucena A
Article. 10.3390/ph14101015. 2021
Pharmacotherapeutic management of advanced therapy medicinal products
Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia
Article. 10.7399/fh.13036. 2022
Pilot evaluation of home delivery programme in haemophilia
Megias-Vericat, JE; (...); Poveda-Andres, JL
Article. 10.1111/jcpt.12718. 2018
PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS
Vericat, JEM; (...); Iorio, A
Meeting Abstract. 2020
Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process
Valero, S; (...); Poveda, JL
Article. 10.1016/j.yrtph.2018.03.001. 2018
PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019
Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.
García-Robles A; (...); Aguar-Carrascosa M
Letter. 10.1016/j.anpedi.2020.06.008. 2021
Preparation and administration of insulin infusions in neonatology: A national survey.
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Article. 10.1016/j.anpede.2020.06.015. 2021
Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Poveda Andrés JL, Edo Solsona MD
Article. 10.1016/j.farma.2023.06.0131130. 2024
Prevalence of people living with multidrug-resistant HIV and limited treatment options in Spain.
Llibre, Josep M; (...); Alcantara, Felipe Rodriguez
Article. 10.1111/hiv.13650. 2024
Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.
Casadellà M; (...); Noguera-Julian M
Article. 10.1093/jac/dkaa349. 2020
Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review
Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11780. 2021
Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815).
Valencia ME; (...); González J
Article. 10.1016/j.eimce.2024.05.005. 2024
Psychological distress in women and men living with HIV in Spain: a cross-sectional telephone survey
Garriga, C; (...); Rodriguez-Arenas, MA
Article. 10.1136/ebmental-2019-300138. 2020
Pyogenic Vertebral Osteomyelitis: Outcome Variables Analysis in a 116 Patients Cohort at a Tertiary Hospital during the Last 8 YEARS
Gil, JJF; (...); Ivorra, JAR
Meeting Abstract. 2018
Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker
Perez-Alenda, S; (...); Querol, F
Letter. 10.1111/hae.13388. 2018
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
Vigon, L; (...); Esteban, H
Article. 10.1038/s41598-019-48592-5. 2019
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV.
Teira, Ramon; (...); Berenguer, Juan
Article. 10.1371/journal.pone.0249515. 2021
Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes.
Escudero-Sánchez R; (...); Cobo J
Article. 10.1007/s15010-020-01567-5. 2021
Real-world persistence of E/C/F/TAF versus DTG+ABC/3TC regimens for treatment of HIV in a large Spanish cohort: VACH
Teira, R; (...); Gutierrez, M
Meeting Abstract. 2018
Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015
Gonzalez, J; (...); Cohort Spanish HIV Res Network Co
Article. 10.1016/j.eimc.2019.02.007. 2019
Recent infections among newly diagnosed cases of HIV infection in Spain, 2015-2016. National estimates using cohort data.
Hernando V; (...); CoRIS-HIV Biobank
Article. 10.1080/23744235.2021.1893377. 2021
Recomendaciones GEMICOMED/GEIRAS-SEIMC para el manejo de las infecciones y colonizaciones por Candida auris.
Alastruey-Izquierdo A; (...); en nombre de GEMICOMED GEIRAS-SEIMC
Abstract of Published Item. 10.1016/j.riam.2019.06.001. 2019
Response to direct acting antivirals in vertically HIV/HCV co-infected youths
Carrasco, I; (...); CoRISpe-Spanish Natl Cohort
Meeting Abstract. 2019
Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients
Carrasco, I; (...); Navarro, ML
Article. 10.1111/jvh.13308. 2020
Rickettsioses imported by travellers and migrants to Spain attended in the+Redivi network, 2009-2020.
Llenas-Garcia, Jara; (...); Perez-Molina, Jose A.
Article. 10.1093/jtm/taad050. 2023
Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study
Salto-Alejandre, S; (...); Cordero, E
Article. 10.1371/journal.pone.0250796. 2021
Role of HIV in the desire of procreation and motherhood in women living with HIV in Spain: a qualitative approach
Alvarez-del Arco, D; (...); CoRIS
Article. 10.1186/s12905-017-0483-y. 2018
Role of previous systemic antibiotic therapy on the probability of recurrence after an initial episode of Clostridioides difficile infection treated with vancomycin.
Merchante, Nicolas; (...); Merino, Esperanza
Article. 10.1093/jacamr/dlad033. 2023
Safety and Tolerability of More than Six Days of Tedizolid Treatment
Vendrell, MM; (...); Viladomiu, AS
Article. 10.1128/AAC.00356-20. 2020
Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.
Article. 10.1111/ajt.14580. 2018
SARS-CoV-2 N protein IgG antibody detection employing nanoporous anodized alumina: A rapid and selective alternative for identifying naturally infected individuals in populations vaccinated with spike protein (S)-based vaccines
Esteve-Sanchez, Yoel; (...); Climent, Estela
Article. 10.1016/j.snb.2024.136378. 2024
SARS-COV-2 viral RNA detection through oligonucleotide-capped nanoporous anodic alumina supports.
Lopez-Palacios, Alba; (...); Climent, Estela
Article. 10.1016/j.snr.2025.100298. 2025
SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11565. 2020
Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus.
Len O; (...); Domínguez-Gil B
Review. 10.1016/j.trre.2020.100528. 2020
Sex differences in hospitalized adult patients with cellulitis: A prospective, multicenter study.
Collazos J; (...); Asensi V
Article. 10.1016/j.ijid.2021.01.044. 2021
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort
Teira, Ramon; (...); Curran, Adria
Article. 10.1007/s40121-022-00630-y. 2022
SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization
Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis
Article. 10.1111/jcpt.13703. 2022
Spatiotemporal Characteristics of the Largest HIV-1 CRF02_AG Outbreak in Spain: Evidence for Onward Transmissions
Kostaki, EG; (...); CoRIS
Article. 10.3389/fmicb.2019.00370. 2019
Switching to a dual regimen with the combination of boosted darunavir plus raltegravir in severely experienced patients: a multicentre, retrospective analysis
Casado, J; (...); de Santiago, AD
Meeting Abstract. 2018
Switching to bictegravir/ emtricitabine/tenofovir alafenamide plus darunavir/cobicistat in heavily antiretroviralexperienced, virologically suppressed HIV-infected adults receiving complex regimens: 48-week analysis
Podzamczer, D.; (...); Rivero, A.
Meeting Abstract. 2023
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
Podzamczer, Daniel; (...); Rivero, Antonio
Article. 10.1093/jac/dkad285. 2023
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
Megías-Vericat JE; (...); Montesinos P
Review. 10.3390/pharmaceutics14040878. 2022
The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations.
Guerrero-Beltrán C; (...); Moreno S
Article. 10.1093/jac/dkaa009. 2020
The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity
Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar
Article. 10.1007/s00431-022-04628-z. 2022
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Gil-Nagel A; (...); Gil A
Article. 10.1016/j.yebeh.2022.108711. 2022
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Badia, Xavier; (...); Valles, Joan-Antoni
Article. 10.1186/s13023-024-03324-5. 2024
The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus
Torrent-Farnell, J; (...); Lizan, L
Article. 10.1016/j.healthpol.2018.03.002. 2018
Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.
Marques MR; (...); Mangas-Sanjuan V
Article. 10.1111/apa.14944. 2020
Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy
Del Rio-Bermudez, C; (...); Poveda, JL
Editorial Material. 10.1186/s40545-020-00276-6. 2020
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.
Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis
Article. 10.1136/ejhpharm-2024-004184. 2024
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.
Vinuela, Laura; (...); Garcia, Federico
Article. 10.1002/jmv.29287. 2023
Trends in imported infections among migrants and travellers to Spain: a decade of analysis through the +Redivi network (2012-2022).
Alkaissy Y; (...); Perez-Molina JA
Article. 10.1093/jtm/taae067. 2024
Trends in Imported Malaria during the COVID-19 pandemic, Spain (+Redivi Collaborative Network).
Norman, Francesca F.; (...); Perez-Molina, Jose A.
Article. 10.1093/jtm/taac083. 2022
Tuberculosis of the elbow: A rare form of presentation of extrapulmonary tuberculosis.
Castaño Aroca MJ; (...); Gil-Brusola, A
Letter. 10.1016/j.eimc.2018.08.002. 2019
Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?
Bejar, S; (...); Mateu, PN
Meeting Abstract. 2020
Unplanned pregnancies and social and partner support during pregnancy in Spanish women living with HIV.
Ruiz-Alguero, Marta; (...); Jarrin, Inma
Article. 10.1111/hiv.13469. 2023
Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy
Garcia, SV; (...); Andres, JLP
Article. 10.1016/j.yrtph.2018.10.002. 2018
USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Dominguez Hernandez, L.; (...); Gomez Segui, I
Meeting Abstract. 2019
Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease.
Lozano N; (...); Osuna A
Article. 10.1371/journal.pone.0282814. 2023
VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA
Poveda, J. L.; (...); Lizan, L.
Meeting Abstract. 2023
VDR rs2228570 Polymorphism Is Related to Non-Progression to AIDS in Antiretroviral Therapy Naive HIV-Infected Patients
Jimenez-Sousa, MA; (...); LTNPs Cohort
Article. 10.3390/jcm8030311. 2019
-
-
PlumX Metrics
- Citations
- Citation Indexes: 9
- Policy Citations: 1
- Captures
- Readers: 37
- Mentions
- Blog Mentions: 1
VERTEBRAL OSTEOMYELITIS IN THE IMMUNOSUPPRESSED PATIENTS
Fragio-Gil, JJ; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6621. 2019